Retatrutide side effects: what the research says so far GI side effects such as nausea, vomiting, diarrhea, constipation, bloating, and abdominal pain reported
Sheehan, A
Why Retatrutide Is Studied for Obesity and Type 2 Diabetes Retatrutide is studied in obesity and type 2 diabetes because GLP-1, GIP, and glucagon signaling each influence appetite, insulin secretion, glucose regulation, body weight, or energy metabolism [1], [5], 10
The observed association between longer durations of GLP-1 agonist use and reductions in nicotine cravings was borderline in the adjusted analysis (aOR 1.03 per month, p = 0.074) highlights the importance of sustained therapy
Researchers continue to explore its ability to protect digestive tissues during physical stress